ACGL Deep Coverage Review — Analysis as of August 11, 2026
Arch Capital remains a high-quality underwriter, but cycle pressure, macro risk and relative weakness leave the turn unconfirmed.
Market Outlooks
Midday Market Check — Tuesday, August 11, 2026
Midday Market Check for Tuesday, August 11, 2026. Where the session stands: breadth, sectors, and what moved.
WST Research Note — The Multiple Faces CPI
West Pharmaceutical is growing with net cash, but CPI and Treasury yields will test whether its premium multiple can hold.
WST Deep Coverage Review — Analysis as of August 11, 2026
West Pharmaceutical has durable growth and net cash, but a 35.34× forward multiple makes Treasury yields the immediate test.
SPCX Research Note — Supply Calendar Still Open
SPCX recovered above its issue price after the first ownership release, but November reporting and December supply keep the evidence incomplete.
SPCX Deep Coverage Review — Analysis as of August 11, 2026
SPCX cleared its first ownership release, but extreme valuation and a larger December supply test leave the public-market thesis unresolved.
Morning Market Brief — Tuesday, August 11, 2026
Morning Market Brief for Tuesday, August 11, 2026. Index futures, the overnight tape, and the calendar that matters today.
ASML Research Note — The Cycle Needs Its Own Proof
ASML’s operating quality and TSM demand support the cycle, but bookings and export-policy evidence remain the missing confirmation.
ASML Deep Coverage Review — Analysis as of August 11, 2026
ASML’s EUV monopoly and TSM demand support the cycle, but bookings, export-policy risk and 4.41% daily volatility leave confirmation incomplete.
QQQ Research Note — Three Tests for the Recovery
QQQ recovered above its 50-day average, but CPI, Treasury yields and two semiconductor reports will test whether the rebound can broaden.